Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea

Adult Population ◽

Polysaccharide Vaccine ◽

Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

Value in Health ◽

10.1016/j.jval.2017.08.2308 ◽

2017 ◽

Vol 20 (9) ◽

pp. A788

Author(s):

D Park ◽

S Kang

Keyword(s):

Cost Effectiveness ◽

South Korea ◽

Conjugate Vaccine ◽

Adult Population ◽

Polysaccharide Vaccine ◽

VACCINATING OLDER ADULTS IN JAPAN WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb3 ◽

2016 ◽

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

VACCINATING OLDER ADULTS IN KOREA WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb8 ◽

2016 ◽

Cited By ~ 1

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

Value in Health ◽

10.1016/j.jval.2017.08.2909 ◽

2017 ◽

Vol 20 (9) ◽

pp. A930 ◽

Cited By ~ 1

Author(s):

Y Jiang ◽

X Yang ◽

T Petigara ◽

L Chabrol Haas ◽

J Graham

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

Value in Health ◽

10.1016/j.jval.2012.08.003 ◽

2012 ◽

Vol 15 (7) ◽

pp. A602 ◽

Cited By ~ 1

Author(s):

D.B.C. Wu ◽

C.J. Chang ◽

L. Chien ◽

H.C.H. Fang ◽

C.S. Roberts

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

The Cost

A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2018.04.3456 ◽

2018 ◽

Vol 73 ◽

pp. 13

Author(s):

E. Prieto ◽

Y. Jiang ◽

X. Yang ◽

J.B. Graham ◽

H. Monsanto ◽

...

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Cost-effectiveness analysis of pneumococcal conjugate vaccine introduction in Paraguay

Vaccine ◽

10.1016/j.vaccine.2014.12.078 ◽

2015 ◽

Vol 33 ◽

pp. A143-A153 ◽

Cited By ~ 10

Author(s):

Martha Peña Kieninger ◽

Edgar Giménez Caballero ◽

Antonio Arbo Sosa ◽

Carlos Torres Amarilla ◽

Bárbara Jáuregui ◽

...

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Vaccine Introduction ◽

Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1870396 ◽

2021 ◽

pp. 1-8

Author(s):

Caixia Wang ◽

Li Su ◽

Qiuling Mu ◽

Xueyan Gu ◽

Xuejun Guo ◽

...

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Mainland China ◽

Effectiveness Analysis ◽

Children Under 5

A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan

Journal of Medical Economics ◽

10.1080/13696998.2018.1465272 ◽

2018 ◽

Vol 21 (7) ◽

pp. 687-697 ◽

Cited By ~ 4

Author(s):

Yiling Jiang ◽

Xiaoqin Yang ◽

Kazuko Taniguchi ◽

Tanaz Petigara ◽

Machiko Abe

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

Catch Up

PIN1 COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE FOR HIGH RISK PATIENTS IN THE PERSPECTIVE OF BRAZILIAN NIP

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.232 ◽

2019 ◽

Vol 19 ◽

pp. S40

Author(s):

R.F. Alexandre ◽

C. Salgado De Santana ◽

T. Senna ◽

J. Spinardi ◽

R. Sini

Keyword(s):

Cost Effectiveness ◽

High Risk ◽

Conjugate Vaccine ◽

High Risk Patients ◽

Effectiveness Analysis ◽

Risk Patients